A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies

Journal of Immunology

Volumn 183, Issue 6, 2009, Pages 4088-4093

  Nishie, Wataru ^a   Sawamura, Daisuke ^a,b   Natsuga, Ken ^a   Shinkuma, Satoru ^a   Goto, Maki ^a   Shibaki, Akihiko ^a   Ujiie, Hideyuki ^a   Olasz, Edit ^c   Yancey, Kim B ^d   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COLLAGEN TYPE 17; COMPLEMENTARY DNA; IMMUNOGLOBULIN G; MATERNAL ANTIBODY; AUTOANTIGEN; NONFIBRILLAR COLLAGEN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; BLISTER; BULLOUS PEMPHIGOID; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENE TARGETING; GENETIC MANIPULATION; GENETIC TRANSFORMATION; MOUSE; NEWBORN DISEASE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN BINDING; PROTEIN DOMAIN; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; FETOMATERNAL TRANSFUSION; HUMAN; IMMUNOLOGY; NEWBORN; PREGNANCY;

ANIMALS; ANIMALS, NEWBORN; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; MICE; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; PREGNANCY;

EID: 70349321267     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0800389     Document Type: Article

References (28)

1. Kohler, P. F., and R. S. Farr. 1966. Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport. Nature 210: 1070-1071.
2. Van de Perre, P. 2003. Transfer of antibody via mother's milk. Vaccine 21: 3374-3376.
3. Lee, L. A. 1993. Neonatal lupus erythematosus. J. Invest. Dermatol. 100: 9S-13S.
4. Lee, L. A., M. B. Frank, V. R. McCubbin, and M. Reichlin. 1994. Autoantibodies of neonatal lupus erythematosus. J. Invest. Dermatol. 102: 963-966.
5. Vernet-der Garabedian, B., M. Lacokova, B. Eymard, E. Morel, M. Feltin, J. Zajac, O. Sadovsky, M. Dommergues, and J. F. Bach. 1994. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor. J. Clin. Invest. 94: 555-559.
6. Ni, H., P. Chen, C. M. Spring, E. Sayeh, J. W. Semple, A. H. Lazarus, R. O. Hynes, and J. Freedman. 2006. A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. Blood 107: 2976-2983.
7. van der Neut, R., P. Krimpenfort, J. Calafat, C. M. Niessen, and A. Sonnenberg. 1996. Epithelial detachment due to absence of hemidesmosomes in integrin β 4 null mice. Nat. Genet. 13: 366-369.
8. Georges-Labouesse, E., N. Messaddeq, G. Yehia, L. Cadalbert, A. Dierich, and M. Le Meur. 1996. Absence of integrin α 6 leads to epidermolysis bullosa and neonatal death in mice. Nat. Genet. 13: 370-373. (Pubitemid 26230508)
9. Ryan, M. C., K. Lee, Y. Miyashita, and W. G. Carter. 1999. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J. Cell Biol. 145: 1309-1323.
10. Heinonen, S., M. Männikkö, J. F. Klement, D. Whitaker-Menezes, G. F. Murphy, and J. Uitto. 1999. Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J. Cell. Sci. 112: 3641-3648.
11. Meng, X., J. F. Klement, D. A. Leperi, D. E. Birk, T. Sasaki, R. Timpl, J. Uitto, and L. Pulkkinen. 2003. Targeted inactivation of murine laminin γ2-chain gene recapitulates human junctional epidermolysis bullosa. J. Invest. Dermatol. 121: 720-731. (Pubitemid 37239113)
12. Nishie, W., D. Sawamura, M. Goto, K. Ito, A. Shibaki, J. R. McMillan, K. Sakai, H. Nakamura, E. Olasz, K. B. Yancey, et al. 2007. Humanization of autoantigen. Nat. Med. 14: 378-383.
13. Anhalt, G. J., C. F. Bahn, R. S. Labib, J. J. Voorhees, A. Sugar, and L. A. Diaz. 1981. Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. J. Clin. Invest. 68: 1097-1101. (Pubitemid 11023539)
14. Liu, Z., L. A. Diaz, J. L. Troy, A. F. Taylor, D. J. Emery, J. A. Fairley, and G. J. Giudice. 1993. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen. BP180. J. Clin. Invest. 92: 2480-2488.
15. Korman, N. 1987. Bullous pemphigoid. J. Am. Acad. Dermatol. 16: 907-924.
16. Stanley, J. R., P. Hawley-Nelson, S. H. Yuspa, E. M. Shevach, and S. I. Katz. 1982. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 24: 897-903.
17. Gatalica, B., L. Pulkkinen, K. Li, K. Kuokkanen, M. Ryynänen, J. A. McGrath, and J. Uitto. 1997. Cloning of the human type XVII collagen gene (COL17A1), and detection of novel mutations in generalized atrophic benign epidermolysis bullosa. Am. J. Hum. Genet. 60: 352-365.
18. Zillikens, D., P. A. Rose, S. D. Balding, Z. Liu, M. Olague-Marchan, L. A. Diaz, and G. J. Giudice. 1997. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J. Invest. Dermatol. 109: 573-579.
19. Olasz, E. B., J. Roh, C. L. Yee, K. Arita, M. Akiyama, H. Shimizu, J. C. Vogel, and K. B. Yancey. 2007. Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice. J. Invest. Dermatol. 127: 2807-2817.
20. Sitaru, C., M. T. Chiriac, S. Mihai, J. Büning, A. Gebert, A. Ishiko, and D. Zillikens. 2006. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J. Immunol. 177: 3461-3468.
21. Appleby, P., and D. Catty. 1983. Transmission of immunoglobulin to foetal and neonatal mice. J. Reprod. Immunol. 5: 203-213.
22. 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice. J. Immunol. 154: 6246-6251.
23. McGrath, J. A., B. Gatalica, A. M. Christiano, K. Li, K. Owaribe, J. R. McMillan, R. A. Eady, and J. Uitto. 1995. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat. Genet. 11: 83-86.
24. Shimizu, H., Y. Takizawa, L. Pulkkinen, J. J. Zone, K. Matsumoto, T. Saida, J. Uitto, and T. Nishikawa. 1998. The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1. J. Invest. Dermatol. 111: 887-892.
25. Pihlgren, M., A. Fulurija, M. B. Villiers, C. Tougne, P. H. Lambert, C. L. Villiers, and C. A. Siegrist. 2004. Influence of complement C3 amount on IgG responses in early life: immunization with C3b-conjugated antigen increases murine neonatal antibody responses. Vaccine. 23: 329-335.
26. Baudino, L., S. Azeredo da Silveria, M. Nakata, and S. Izui. 2006. Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies. Springer. Semin. Immunopathol. 28: 175-184.
27. Liu, Z., G. J. Giudice, S. J. Swartz, J. A. Fairley, G. O. Till, J. L. Troy, and L. A. Diaz. 1995. The role of complement in experimental bullous pemphigoid. J. Clin. Invest. 95: 1539-1544.
28. Nelson, K. C., M. Zhao, P. R. Schroeder, N. Li, R. A. Wetsel, L. A. Diaz, and Z. Liu. 2006. Role of different pathways of the complement cascade in experimental bullous pemphigoid. J. Clin. Invest. 116: 2892-2900.